The US Food and Drug Administration's emergency use authorization of Pfizer and BioNTech's coronavirus vaccine is a crucial step in developing the new-generation vaccine, BioNTech CEO Ugur Sahin says.

December 12, 2020 at 01:11PM https://ift.tt/3a3pIzb US Food and Drug Administration's emergency use authorization of Pfizer and BioNTech's coronavirus vaccine is a crucial step in developing the new-generation vaccine, BioNTech CEO Ugur Sahin says.
No comments:
Post a Comment